Literature DB >> 16297799

Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion.

Masashi Tanaka1, Golnaz K Mokhtari, Raya D Terry, Feny Gunawan, Leora B Balsam, Grant Hoyt, Keun-Ho Lee, Philip S Tsao, Robert C Robbins.   

Abstract

BACKGROUND: Prolonged cold ischemia is thought to exacerbate ischemia-reperfusion injury and graft coronary artery disease (GCAD). We investigated the effect of varying lengths of cold ischemia on inflammation and apoptosis during ischemia-reperfusion injury and correlated this with the degree of GCAD in rat cardiac allografts.
METHODS: PVG rat (RT1c) hearts subjected to 30, 60, 90, 120, or 150 minutes of cold ischemia were heterotopically transplanted into ACI rats (RT1a). Grafts were procured after 4 hours of reperfusion and analyzed for superoxide generation, myeloperoxidase activity, tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and monocyte chemoattractant protein-1/chemokine (C-C motif) ligand 2 (MCP-1/CCL2) production, cardiomyocyte apoptosis, and caspase-2, -3, -8, -9 activities. Additional transplanted animals received cyclosporine A (7.5 mg/kg/day) for 10 days as chronic rejection models. Indices of GCAD were determined at 90 days.
RESULTS: A direct linear correlation was found between cold ischemic time, ischemia-reperfusion injury, and GCAD. Superoxide generation, myeloperoxidase activity, TNF-alpha, IL-1beta, MCP-1/CCL2 production, cardiomyocyte apoptosis, and caspase-2, -3, -8, and -9 activities increased with ischemic time, peaking at 120 minutes and plateauing at 150 minutes. GCAD, assessed by the percentage of luminal narrowing, the intima/media ratio, and the percentage of diseased vessels, worsened with increased ischemic time, peaking at 120 minutes and plateauing at 150 minutes. All tested variables in both the acute and chronic phases were significantly increased with 120-minute ischemia compared with 30-minute ischemia.
CONCLUSIONS: These data indicate that the degree of cardiomyocyte apoptosis and inflammatory response in cardiac allografts during ischemia-reperfusion injury depends on the duration of cold ischemia. More important, that prolonged cold ischemia correlates with increased GCAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297799     DOI: 10.1016/j.healun.2004.06.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

Review 1.  Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients.

Authors:  Matteo Santoni; Francesco Massari; Stefano Cascinu
Journal:  Cell Mol Immunol       Date:  2014-06-02       Impact factor: 11.530

2.  A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection.

Authors:  Jocelyn T Chin; Joshua J Troke; Naoyuki Kimura; Satoshi Itoh; Xi Wang; Owen P Palmer; Robert C Robbins; Michael P Fischbein
Journal:  Yale J Biol Med       Date:  2011-12

3.  Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice.

Authors:  Ling Hou; Gang Chen; Biao Feng; Xu-Sheng Zhang; Xiu-Fen Zheng; Ying Xiang; Guang-Yuan Zhao; Wei-Ping Min
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

4.  Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy.

Authors:  Chelsey L King; Jennifer J Devitt; Timothy D G Lee; Camille L Hancock Friesen
Journal:  J Cardiothorac Surg       Date:  2010-06-22       Impact factor: 1.637

Review 5.  Chemokines and transplant vasculopathy.

Authors:  John A Belperio; Abbas Ardehali
Journal:  Circ Res       Date:  2008-08-29       Impact factor: 17.367

6.  Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy.

Authors:  Jennifer J Devitt; Chelsey L King; Timothy D G Lee; Camille L Hancock Friesen
Journal:  J Cardiothorac Surg       Date:  2011-01-06       Impact factor: 1.637

7.  Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation.

Authors:  Giuseppe Vassalli; Giuseppina Milano; Tiziano Moccetti
Journal:  J Transplant       Date:  2012-03-18

8.  The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.

Authors:  Anna J Dare; Angela Logan; Tracy A Prime; Sebastian Rogatti; Martin Goddard; Eleanor M Bolton; J Andrew Bradley; Gavin J Pettigrew; Michael P Murphy; Kourosh Saeb-Parsy
Journal:  J Heart Lung Transplant       Date:  2015-06-11       Impact factor: 10.247

9.  Impaired Endothelial Nitric Oxide Synthase Homodimer Formation Triggers Development of Transplant Vasculopathy - Insights from a Murine Aortic Transplantation Model.

Authors:  Rupert Oberhuber; Gregor Riede; Benno Cardini; David Bernhard; Barbara Messner; Katrin Watschinger; Christina Steger; Gerald Brandacher; Johann Pratschke; Georg Golderer; Ernst R Werner; Manuel Maglione
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

10.  MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation.

Authors:  Liangyi Zhou; Guoyao Zang; Guangfeng Zhang; Hansong Wang; Xusheng Zhang; Nathan Johnston; Weiping Min; Patrick Luke; Anthony Jevnikar; Aaron Haig; Xiufen Zheng
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.